Get my own profile
Public access
View all26 articles
6 articles
available
not available
Based on funding mandates
Co-authors
- Yoonjeong ChaMITVerified email at mit.edu
- Huixiao HongNational Center for Toxicological ResearchVerified email at fda.hhs.gov
- Iris GrossmanChief Therapeutics Officer, Eleven TherapeuticsVerified email at grossmail.com
- John QuackenbushHarvard T.H. Chan School of Public Health, Channing Division of Network Medicine, and Dana-FarberVerified email at hsph.harvard.edu
- Michael HaydenKillam Professor, University of British ColumbiaVerified email at cmmt.ubc.ca
- Sarah KolitzImmuneeringVerified email at immuneering.com
- Weida TongNCTRVerified email at FDA.HHS.gov
- Jennifer BeaneBoston University School of MedicineVerified email at bu.edu
- Dr. Jermaine RossAlleo LabsVerified email at alleolabs.com
- Fadi TowficPrometheus BiosciencesVerified email at prometheusbiosciences.com
- John F. Brothers IIBioinformatics ScientistVerified email at immuneering.com
- John TedrowSt. Elizabeth's Medical CenterVerified email at steward.org
- David A. SchwartzProfessor of Medicine and Immunology, University of ColoradoVerified email at ucdenver.edu
- Naftali KaminskiYale School of MedicineVerified email at yale.edu
- Brenda Juan-GuardelaPulmonary and Critical Care Physician, NCH Healthcare SystemVerified email at nchmd.org
- Frank C SciurbaUniversity of PittsburghVerified email at upmc.edu
- Andrew LysaghtImmuneering Corp., Ph.D., Harvard-MIT Joint Division of Health Sciences and TechnologyVerified email at alum.mit.edu
- Brian WeinerSeres TherapeuticsVerified email at serestherapeutics.com
- Benjamin Haibe-KainsScientist (Principal Investigator), Princess Margaret Cancer Centre, University Health NetworkVerified email at uhnresearch.ca
- S PapapetropoulosConsultant, Massachusetts General Hospital, Department of NeurologyVerified email at mgh.harvard.edu